I hear you mate, and respect the honesty this one’s not for the...

I hear you mate, and respect the honesty this one’s not for the faint-hearted, that’s for sure. But here’s the thing: we’ve got confirmed sulphides, assays landing any week now, a $1.5B BHP rail corridor next door, and an R&D tax rebate that doesn’t get handed out lightly. The $1.5M SPP raise was fully underwritten not a desperate raise, but strategic capital ahead of assay results. Management is also taking shares instead of cash. That’s not what you do when you’re worried about survival that’s what you do when you’re positioning for upside.Yes, capital will always be needed in this sector. But smart management doesn’t raise at the bottom they raise on strength. These assays are the key trigger. If they confirm scale, funding becomes a queue, not a question.And also let’s be real for a moment. If you were Julian Babarczy, would you waste time on a tiny microcap like Lincoln unless you saw serious upside? People like that don’t hang around penny stocks for fun. He’s not here for tax losses he’s here to build something with leverage and value. Everything about his involvement says: he knows what’s coming before the rest of the market does.You’re not alone in this but you’ll want to be holding when the re-rate starts.